Department of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.
Medicine (Baltimore). 2022 Oct 21;101(42):e31160. doi: 10.1097/MD.0000000000031160.
We have implemented several preventive measures to reduce central line-associated bloodstream infection (CLABSI) in the general intensive care unit (ICU) of a university hospital in Japan. Here, we analyzed the factors associated with CLABSI in patients with central venous catheter (CVC) insertions and evaluated the effects of our implemented preventive measures. From July 2013 to June 2018, data was collected from the medical records of 1472 patients with 1635 CVC insertions, including age, sex, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, duration of ICU stay, duration of catheter insertion, insertion site, and mechanical ventilation status. During weekly conferences, a surveillance team comprising intensive care and infection control doctors and nurses determined the patients' CLABSI status. The analyzed factors were compared between CLABSI and central line patients without bloodstream infection. Multivariate analysis revealed three factors associated with CLABSI. Adjusted odds ratios with 95% confidence intervals were as follows: duration of ICU stay, 1.032 (1.019-1.044); duration of catheter insertion, 1.041 (1.015-1.066); and APACHE II score, 1.051 (1.000-1.105). The prominent risk factors were associated with the severity of the initial condition and exacerbation of the clinical condition of the patients during their stays in the ICU. Further strategies to reduce CLABSI must be developed.
我们在日本一所大学医院的普通重症监护病房(ICU)实施了多项预防措施,以降低中心静脉导管相关血流感染(CLABSI)的发生率。在此,我们分析了与中心静脉导管(CVC)置管患者 CLABSI 相关的因素,并评估了我们实施的预防措施的效果。2013 年 7 月至 2018 年 6 月,我们从 1472 例 1635 次 CVC 置管患者的病历中收集数据,包括年龄、性别、急性生理学和慢性健康评估 II (APACHE II)评分、ICU 住院时间、导管插入时间、插入部位和机械通气状态。在每周的会议上,由重症监护和感染控制医生和护士组成的监测小组确定患者的 CLABSI 状态。比较 CLABSI 患者和无血流感染的中心静脉导管患者的分析因素。多因素分析显示与 CLABSI 相关的三个因素。调整后的比值比及其 95%置信区间如下:ICU 住院时间,1.032(1.019-1.044);导管插入时间,1.041(1.015-1.066);APACHE II 评分,1.051(1.000-1.105)。主要危险因素与患者入住 ICU 期间初始病情的严重程度和临床病情恶化有关。必须制定进一步降低 CLABSI 的策略。